Detailing formulation approaches by stage of discovery to early development, this book gives a “playbook” of practical and efficient strategies to formulate drug candidates with the least chance of failing in clinical development.
• Comes from contributing authors with experience developing formulations on the frontlines of the pharmaceutical industry
• Focuses on pre (or non-) clinical and early stage development, the phases where most compounds are used in drug research
• Features case studies to illustrate practical challenges and solutions in formulation selection
• Covers regulatory filing, drug metabolism and physical and chemical properties, toxicology formulation, biopharmaceutics classification system (BCS), screening approaches, early stage clinical formulation development, and outsourcing
"Sinopsis" puede pertenecer a otra edición de este libro.
Elizabeth Kwong, PhD, retired from Merck & Co., Inc. in 2011, after 23 years of service. She then established her own company, Kwong Eureka Solutions, as a consultant for small start-up companies and specialty drug products. Dr. Kwong is on the Board of Directors for the Canadian Society of Pharmaceutical Scientists and is also an adjunct professor in the Department of Pharmaceutics at the University of Montreal and Department of Chemistry at Concordia University. More recently, Dr. Kwong also co-founded a start-up company, Giiant Pharma, working on delivering a colon specific PDEIV Inhibitor prodrug for the treatment of ulcerative colitis.
Many of the challenges facing drug discovery and development stem from a failure to properly identify formulations that translate from preclinical to clinical phases. Further, a lack of collaboration and proper integration between formulation and discovery scientists contribute significantly to most failures in the clinic. Lastly, the regulatory requirements for formulations also increase the timelines and costs of bringing a drug candidate forward.
Written to address these many challenges and issues, this book describes and explains the key factors that help determine the types of formulation needed throughout the stages of drug discovery. Detailing formulation approaches by stage of discovery to early development, Oral Formulation Roadmap from Early Drug Discovery to Development gives a “playbook” of practical and efficient strategies to formulate drug candidates with the least chance of failing in clinical development.
A key reference for practicing pharmaceutical scientists, this book provides a valuable resource that:
• Comes from contributing authors with experience developing formulations on the frontlines of the pharmaceutical industry
• Focuses on pre (or non-) clinical and early stage development, the phases where most compounds are used in drug research
• Features case studies to illustrate practical challenges and solutions
• Covers regulatory filing, drug metabolism and properties, biopharmaceutics classification system (BCS), screening approaches, toxicology studies, clinical formulation development, and outsourcing"Sobre este título" puede pertenecer a otra edición de este libro.
EUR 3,00 gastos de envío desde Irlanda a España
Destinos, gastos y plazos de envíoEUR 25,39 gastos de envío desde Estados Unidos de America a España
Destinos, gastos y plazos de envíoLibrería: killarneybooks, Inagh, CLARE, Irlanda
Hardcover. Condición: Very Good. 1st Edition. Hardcover, x + 252 pages, NOT ex-library. Book is clean and bright throughout with unmarked text, free of inscriptions and stamps, firmly bound. A tiny crease to the tip of upper corner of several leaves. Issued without a dust jacket. -- Contents: 1 Introduction / Elizabeth Kwong; 2 Lead Identification/Optimization / Mei Wong & Mark McAllister; 3 Oral Drug Formulation Development in Pharmaceutical Lead Selection Stage / Shayne Cox Gad; 4 Bridging End of Discovery to Regulatory Filing: Formulations for IND? and Registration?Enabling Nonclinical Studies / Evan A. Thackaberry; 5 Planning the First Clinical Trials with Clinical Manufacturing Organization (CMO) / Elizabeth Kwong & Caroline McGregor; 6 Formulation Strategies for High Dose Toxicology Studies: Case Studies / Dennis H. Leung; 7 Formulation, Analytical, and Regulatory Strategies for First?in?Human Clinical Trials / Lorenzo Capretto; Index -- Many of the challenges facing drug discovery and development stem from a failure to properly identify formulations that translate from preclinical to clinical phases. Further, a lack of collaboration and proper integration between formulation and discovery scientists contribute significantly to most failures in the clinic. Lastly, the regulatory requirements for formulations also increase the timelines and costs of bringing a drug candidate forward. Written to address these many challenges and issues, this book describes and explains the key factors that help determine the types of formulation needed throughout the stages of drug discovery. Detailing formulation approaches by stage of discovery to early development, Oral Formulation Roadmap from Early Drug Discovery to Development gives a 'playbook' of practical and efficient strategies to formulate drug candidates with the least chance of failing in clinical development. A key reference for practicing pharmaceutical scientists, this book provides a valuable resource that: - Comes from contributing authors with experience developing formulations on the frontlines of the pharmaceutical industry; - Focuses on pre (or non-) clinical and early stage development, the phases where most compounds are used in drug research; - Features case studies to illustrate practical challenges and solutions; - Covers regulatory filing, drug metabolism and properties, biopharmaceutics classification system (BCS), screening approaches, toxicology studies, clinical formulation development, and outsourcing. Nº de ref. del artículo: 007161
Cantidad disponible: 1 disponibles
Librería: Goodwill of Silicon Valley, SAN JOSE, CA, Estados Unidos de America
Condición: acceptable. Supports Goodwill of Silicon Valley job training programs. The cover and pages are in Acceptable condition! Any other included accessories are also in Acceptable condition showing use. Use can include some highlighting and writing, page and cover creases as well as other types visible wear such as cover tears discoloration, staining, marks, scuffs, etc. All pages intact. Nº de ref. del artículo: GWSVV.1118907337.A
Cantidad disponible: 1 disponibles
Librería: Basi6 International, Irving, TX, Estados Unidos de America
Condición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Nº de ref. del artículo: ABEJUNE24-313724
Cantidad disponible: 3 disponibles
Librería: ALLBOOKS1, Direk, SA, Australia
Brand new book. Fast ship. Please provide full street address as we are not able to ship to P O box address. Nº de ref. del artículo: SHUB313724
Cantidad disponible: 1 disponibles
Librería: GoldBooks, Denver, CO, Estados Unidos de America
Condición: new. Nº de ref. del artículo: 97K85_65_1118907337
Cantidad disponible: 1 disponibles
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Condición: New. Nº de ref. del artículo: 21044413-n
Cantidad disponible: 9 disponibles
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
HRD. Condición: New. New Book. Shipped from UK. Established seller since 2000. Nº de ref. del artículo: FW-9781118907337
Cantidad disponible: 1 disponibles
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
Condición: New. Nº de ref. del artículo: 21044413-n
Cantidad disponible: 9 disponibles
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Condición: As New. Unread book in perfect condition. Nº de ref. del artículo: 21044413
Cantidad disponible: 9 disponibles
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
Condición: As New. Unread book in perfect condition. Nº de ref. del artículo: 21044413
Cantidad disponible: 9 disponibles